Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources

NCT05196581 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Dispersible NaCl powder 10 sessions
DRUG: Dispersible NaCl powder 5 sessions

Sponsor

Suzana Erico Tanni Minamoto

Collaborators

[object Object]